BioNexus Gene Lab (BGLC) Share-based Compensation (2023 - 2025)
BioNexus Gene Lab recorded quarterly Share-based Compensation of $794770.0 in Q4 2025, up 983.07% quarter-over-quarter from -$90001.0 in Q4 2023.
BioNexus Gene Lab's Share-based Compensation history runs 2 years deep, the most recent figure standing at $794770.0 for Q4 2025.
- In Q4 2025, Share-based Compensation changed N/A year-over-year to $794770.0; the TTM figure through Dec 2025 stood at $704769.0 (changed N/A YoY), while the FY2025 annual figure was $794770.0, up 463.67% from the prior year.
- Share-based Compensation came in at $794770.0 for Q4 2025 at BioNexus Gene Lab, up from -$90001.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $794770.0 in Q4 2025 to a low of -$90001.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 41.00 Mn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 29.50 Mn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 27.10 Mn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 15.90 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 11.00 Mn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 47.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 7.88 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 13.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 794,770.00 |
| Dec 31, 2025 | 794,770.00 |
| Dec 31, 2023 | -90,001.00 |
| Dec 31, 2023 | -90,001.00 |